KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $499.0 million.

  • Organon's Operating Expenses fell 637.9% to $499.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year decrease of 4304.08%. This contributed to the annual value of $2.3 billion for FY2024, which is 5957.07% down from last year.
  • According to the latest figures from Q3 2025, Organon's Operating Expenses is $499.0 million, which was down 637.9% from $550.0 million recorded in Q2 2025.
  • Organon's Operating Expenses' 5-year high stood at $1.5 billion during Q4 2023, with a 5-year trough of $499.0 million in Q3 2025.
  • Its 5-year average for Operating Expenses is $1.1 billion, with a median of $1.2 billion in 2021.
  • In the last 5 years, Organon's Operating Expenses soared by 4053.4% in 2021 and then tumbled by 6296.04% in 2024.
  • Quarter analysis of 5 years shows Organon's Operating Expenses stood at $1.4 billion in 2021, then grew by 0.51% to $1.4 billion in 2022, then grew by 8.73% to $1.5 billion in 2023, then crashed by 59.3% to $608.0 million in 2024, then fell by 17.93% to $499.0 million in 2025.
  • Its Operating Expenses stands at $499.0 million for Q3 2025, versus $550.0 million for Q2 2025 and $602.0 million for Q1 2025.